HUHS015 potently suppresses the growth of DU145 cells in a mouse xenograft model[1].
HUHS015 displays 7.2% bioavailability (BA) in rats after oral administration[1].
| Animal Model: | Nude mice[1] |
| Dosage: | 32 mg/kg |
| Administration: | Subcutaneous injection; daily; 6 days |
| Result: | Has inhibitory effect on the growth of subcutaneously implanted DU145, without limiting weight gains after a 6 days continuous administration. |